Skip to content

Efficacy Analysis of Indwelling Appendiceal Stents in Visualized Endoscopic Retrograde Appendicitis Therapy (V-ERAT): A Retrospective Cohort Study

Efficacy Analysis of Indwelling Appendiceal Stents in Visualized Endoscopic Retrograde Appendicitis Therapy (V-ERAT): A Retrospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600123967
Enrollment
Unknown
Registered
2026-05-06
Start date
2026-05-06
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Appendicitis

Interventions

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: Appendicitis was suspected by clinical manifestations or auxiliary examination, voluntarily underwent V-ERAT and was confirmed as: 1. Acute uncomplicated appendicitis (including acute simple appendicitis and acute suppurative appendicitis) 2. Acute complicated appendicitis (only appendicitis with periappendiceal abscess was included) 3. Chronic appendicitis (intermittent pain in the right lower abdomen lasting more than a few weeks or with recurrent episodes)

Exclusion criteria

Exclusion criteria: 1. Abdominal pain is caused by other conditions such as colonic diverticulitis, urinary calculi, salpingitis, cholecystitis, cholangitis, and pelvic inflammatory disease 2. Gangrenous appendicitis and appendiceal perforation 3. Patients with other appendiceal diseases such as appendiceal cysts and appendiceal tumors 4. Stenosis or occlusion of the appendiceal opening and failure of appendiceal intubation cannot be treated with ERAT 5. Patients who cannot tolerate colonoscopy or treatment due to severe dysfunction of heart, lung, coagulation system or pregnancy 6. Patients with severe colon stenosis or obstruction who cannot complete colonoscopy or other colonoscopy contraindications 7. Patients lacking baseline characteristics or follow-up data

Design outcomes

Primary

MeasureTime frame
Recurrence rate;

Secondary

MeasureTime frame
Postoperative complications;Technical success;Clinical success;Postoperative pain relief;Clinical efficacy grade;Time to consume a soft diet;Length of postoperative hospital stay and total hospital stay;

Countries

China

Contacts

Public ContactGuoxin Zhang

The First Affiliated Hospital of Nanjing Medical University

lcnjmu@163.com+86 189 2178 7984

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026